Evidence map›Paper›PMID 40159158›Full record

ReviewInternal medicine (Tokyo, Japan)2025

Disseminated Nocardiosis in Idiopathic CD4 Lymphocytopenia: A Rare Case and Literature Review.

Nayuta Seto, Takayuki Suzuki, Takahiko Fukuchi, Momori Honjo, Shinya Watanabe, Longzhu Cui, Hitoshi Sugawara

Abstract readCase ReportsReview
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nayuta SetoDivision of General Medicine, Department of Comprehensive Medicine 1, Jichi Medical University, Saitama Medical Center, Japan.
Takayuki SuzukiDivision of Infectious Diseases, Department of Infection and Immunity, Jichi Medical University, Japan.
Takahiko FukuchiDivision of General Medicine, Department of Comprehensive Medicine 1, Jichi Medical University, Saitama Medical Center, Japan.
Momori HonjoTrauma and Emergency Center, Fukaya Red Cross Hospital, Japan.
Shinya WatanabeDivision of Bacteriology, Department of Infection and Immunity, Jichi Medical University, Japan.
Longzhu CuiDivision of Bacteriology, Department of Infection and Immunity, Jichi Medical University, Japan.
Hitoshi SugawaraDivision of General Medicine, Department of Comprehensive Medicine 1, Jichi Medical University, Saitama Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nocardiosis typically affects immunocompromised patients; however, the clinical characteristics of idiopathic CD4 lymphocytopenia (ICL) remain poorly understood. A 64-year-old patient was diagnosed with ICL following disseminated nocardiosis, including bacteremia, pneumonia, knee arthritis, and brain abscess. The patient underwent trimethoprim-sulfamethoxazole therapy with frequent dose adjustments based on the renal function, ranging from 2 to 12 single-strength tablets daily over 5 months of hospitalization. While he had a 1-year uneventful course of lifelong prophylaxis, he experienced prolonged recovery in physical activity. A literature review highlighted the life-threatening nature of nocardiosis in ICL, underscoring the importance of a timely diagnosis and tailored management strategies.

Indexed as

Nocardia InfectionsT-Lymphocytopenia, Idiopathic CD4-PositiveAnti-Bacterial AgentsHumansMaleMiddle AgedTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsTrimethoprim, Sulfamethoxazole Drug Combinationbacteremiabrain abscessidiopathic CD4 lymphocytopeniaimmunologic deficiency syndromesNocardiaopportunistic infections

Identifiers

PMID40159158
PMCPMC12508639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.